BMS - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

BMS’ CheckMate -915 trial fails to meet one co-primary endpoint

BMS
Bristol-Myers Squibb is developing Opdivo and Yervoy to treat a variety of cancers. Credit: Rept0n1x.